Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.75% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10751
CALL
EverCommerce
EVCM
$1.65B
| $134K | ﹤0.01% |
+12,200
| New | +$118K |
|
10752
PUT
Delcath Systems
DCTH
$569M
| $134K | ﹤0.01% |
16,000
-10,100
| -39% | -$64K |
|
|
CRDL
10753
Cardiol Therapeutics
CRDL
$241M
| $134K | ﹤0.01% |
66,180
+20,511
| +45% | +$43.5K |
|
|
AEVA
10754
Aeva Technologies
AEVA
$1.14B
| $134K | ﹤0.01% |
52,991
-52,288
| -50% | -$171K |
|
10755
Tenaya Therapeutics
TNYA
$156M
| $133K | ﹤0.01% |
43,018
-11,435
| -21% | -$47.2K |
|
|
GHIX
10756
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $133K | ﹤0.01% |
12,649
-1,543
| -11% | -$16.3K |
|
|
DMF
10757
DELISTED
BNY Mellon Municipal Income
DMF
| $133K | ﹤0.01% |
18,540
-29,517
| -61% | -$201K |
|
10758
Green Dot
GDOT
$762M
| $133K | ﹤0.01% |
14,099
-74,161
| -84% | -$690K |
|
10759
PUT
Erasca
ERAS
$6.82B
| $132K | ﹤0.01% |
56,100
+45,400
| +424% | +$98K |
|
10760
PUT
Cricut
CRCT
$1.19B
| $132K | ﹤0.01% |
+22,100
| New | +$133K |
|
10761
BioCardia
BCDA
$17.7M
| $132K | ﹤0.01% |
+44,557
| New | +$223K |
|
10762
CALL
Commercial Vehicle Group
CVGI
$129M
| $132K | ﹤0.01% |
+27,000
| New | +$153K |
|
|
VLRS
10763
CALL
Controladora Vuela Compania de Aviacion
VLRS
$792M
| $132K | ﹤0.01% |
20,800
-45,200
| -68% | -$348K |
|
10764
Kamada
KMDA
$477M
| $132K | ﹤0.01% |
26,321
-2,075
| -7% | -$10.9K |
|
|
LVTX
10765
CALL
DELISTED
LAVA Therapeutics
LVTX
| $132K | ﹤0.01% |
73,100
+55,400
| +313% | +$146K |
|
10766
IRIDEX
IRIX
$12.4M
| $131K | ﹤0.01% |
60,863
-24,510
| -29% | -$65.7K |
|
|
CKPT
10767
DELISTED
Checkpoint Therapeutics
CKPT
| $131K | ﹤0.01% |
61,139
+4,714
| +8% | +$8.39K |
|
|
DTF
10768
DTF Tax-Free Income 2028 Term Fund
DTF
$80.9M
| $131K | ﹤0.01% |
+11,988
| New | +$130K |
|
10769
PUT
Digital Turbine
APPS
$1.38B
| $131K | ﹤0.01% |
79,100
-36,400
| -32% | -$70.5K |
|
|
BRY
10770
PUT
DELISTED
Berry Corp
BRY
| $131K | ﹤0.01% |
20,300
-11,100
| -35% | -$82.6K |
|
10771
Repay Holdings
RPAY
$313M
| $131K | ﹤0.01% |
12,415
-17,747
| -59% | -$181K |
|
10772
Acumen Pharmaceuticals
ABOS
$219M
| $131K | ﹤0.01% |
54,080
-211,763
| -80% | -$674K |
|
10773
FVCBankcorp
FVCB
$330M
| $131K | ﹤0.01% |
11,969
-3,230
| -21% | -$35.8K |
|
10774
OppFi
OPFI
$609M
| $131K | ﹤0.01% |
38,539
-33,714
| -47% | -$103K |
|
10775
PUT
Ocugen
OCGN
$465M
| $130K | ﹤0.01% |
84,100
+50,500
| +150% | +$78.7K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.